NNOX
Nano-X Imaging Ltd.
NNOX's outlook is improving, though it still trails on the overall score.
UNH
UnitedHealth Group Incorporated
UNH has the edge over NNOX overall, supported by lower modeled downside and stronger fundamentals.
NNOX Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Weak | |
| Weak | |
| Unavailable |
NNOX's revenue is currently strong, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
NNOX PE Valuation
NNOX has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
NNOX Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect NNOX's losses to shrink, with revenue growing.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
Analysts expect UNH's earnings to grow and its profitability to improve, with its revenue holding steady. However, they disagree widely on these estimates.
NNOX Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | -$1.70 | -$0.80 |
| Q1 2026 | -$1.14 | -$0.24 |
| Q4 2025 | -$1.15 | -$0.25 |
| Q3 2025 | -$0.88 | -$0.03 |
| Q2 2025 | -$0.90 | +$0.09 |
| Q1 2025 | -$0.90 | +$0.17 |
| Q4 2024 | -$0.90 | +$0.17 |
| Q3 2024 | -$0.85 | +$0.90 |
NNOX is still losing money, but less than at its worst: $1.70 per share over the past year, against $2.03 at its worst in late 2022.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over NNOX on earnings quality, reporting a profit while its opponent remains loss making.
NNOX Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $4.2M | +37% |
| Q1 2026 | $4.3M | +53% |
| Q4 2025 | $3.7M | +24% |
| Q3 2025 | $3.4M | +14% |
| Q2 2025 | $3M | +13% |
| Q1 2025 | $2.8M | +10% |
| Q4 2024 | $3M | +25% |
| Q3 2024 | $3M | +22% |
NNOX has the edge over UNH on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -1335% | -858 points |
| Q1 2026 | -343% | +157 points |
| Q4 2025 | -481% | +18 points |
| Q3 2025 | -413% | +54 points |
| Q2 2025 | -477% | +61 points |
| Q1 2025 | -501% | +12 points |
| Q4 2024 | -499% | +54 points |
| Q3 2024 | -466% | +421 points |
NNOX's operating margin was −1335% last quarter, down 858 points from the same quarter a year ago, near the bottom of its range since 2021.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over NNOX on profitability, with a higher operating margin.
NNOX Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$12.6M | -$2.2M |
| Q1 2026 | -$15.7M | -$4.9M |
| Q4 2025 | -$12.5M | -$922.8K |
| Q3 2025 | -$12.5M | -$3.6M |
| Q2 2025 | -$10.4M | -$1M |
| Q1 2025 | -$10.9M | -$1.3M |
| Q4 2024 | -$11.6M | +$890.5K |
| Q3 2024 | -$8.9M | +$3.5M |
NNOX has burned cash in almost every quarter: −$53M over the past year, against −$42M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over NNOX on cash generation, producing positive trailing cash flow while its opponent burns cash.
NNOX Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +312K shares |
| 1 year | +9.4% | +6M shares |
| 3 years | +26% | +14.6M shares |
| 5 years | +46% | +22.2M shares |
| Available history | +105% | +35.8M shares |
NNOX has 70M diluted shares, up 9.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
NNOX hasn't bought back shares in the past year.
UNH Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.4% | -4M shares |
| 1 year | -0.7% | -6M shares |
| 3 years | -3.6% | -34M shares |
| 5 years | -5.5% | -53M shares |
| Available history | -6.6% | -64M shares |
UNH has the edge over NNOX on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $3.4B |
| Q2 2026 | $1.6B |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | $2.5B |
| Q1 2025 | $3B |
| Q4 2024 | $5B |
UNH spent $5B buying back its own shares over the past year, down 52% from the year before.
NNOX Net Leverage
NNOX's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
NNOX Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 26.9 | Oversold |
| Stochastic | 7.0 | Oversold |
NNOX's weekly RSI is 27 (oversold) and its Stochastic is 7 (oversold).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
NNOX PE vs Healthcare Sector
NNOX has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
NNOX Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.44 | 27% below |
| 20 week MA | $0.75 | 57% below |
| 50 week MA | $1.73 | 82% below |
| 100 week MA | $3.50 | 91% below |
| 200 week MA | $6.06 | 95% below |
NNOX is in a downtrend: it's below all five of its weekly moving averages, and 95% below its 200-week average.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has the edge over NNOX on trend strength, trading above more of its moving averages.
NNOX Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $49.6 | $52.5 | +5.7% |
| 2021 | $52.5 | $17.9 | -66% |
| 2022 | $17.9 | $8.02 | -55% |
| 2023 | $8.02 | $6.37 | -21% |
| 2024 | $6.37 | $7.59 | +19% |
| 2025 | $7.59 | $2.86 | -62% |
| 2026 YTD | $2.86 | $0.32 | -89% |
NNOX has finished lower in four of the last six years. It's down 89% so far in 2026.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has the edge over NNOX on returns for 2026, with the stronger performance.